AMD’s Strategic Crossroads: AI Ambitions Face Profitability Scrutiny
Published on 09/13/2025 at 13:09 | Redaktion boerse-global.deAdvanced Micro Devices (AMD) finds itself navigating contrasting narratives as it pursues leadership in artificial intelligence while facing intensified examination of its financial performance. Recent developments highlight both the semiconductor giant’s ambitious growth initiatives and the mounting pressure on its profit margins.
This week, AMD announced a significant collaboration with Oracle Cloud Infrastructure and biotechnology firm Absci to accelerate AI-powered drug discovery. The initiative centers on deploying AMD’s high-performance Instinct MI355X series GPUs and EPYC CPUs within Oracle’s cloud infrastructure to power Absci’s generative AI platform. This partnership aims to substantially reduce development cycles for biologics and bring new therapies to market faster.
The alliance represents a strategic move to position AMD’s... Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
